Kan T, Takahagi S, Kawai M, Matsubara D, et al. Rechallenge of programmed cell death 1 inhibitor after an interval with dacarbazine treatment may be effective for advanced malignant melanoma. J Dermatol 2020 Jun 8. doi: 10.1111/1346-8138.15408.
PMID: 32515012